miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer

Sabrina T Reis José Pontes-Junior; Alberto Azoubel Antunes; Marcos Francisco Dall'Oglio; Nelson Dip; Carlo Camargo Passerotti; Guilherme Ayres Rossini; Denis Reis Morais; Adriano João Nesrallah; Camila Piantino; Miguel Srougi; Katia R Leite

BMC Urology London v. 12, 6 p., art. 14, 2012

London 2012

Localização: FM - Fac. Medicina    (BCSEP 336 2012 )(Acessar)